Eqitx to raise $1.8 million
By Melissa Trudinger
Tuesday, 07 December, 2004
Tuesday, 07 December, 2004
Melbourne-based biotech managed investment group EQiTX (ASX: EQX) will ask shareholders to approve a AUD$1.8 million capital raising to provide working capital for its two projects ZingoTX and VacTX.
The placement, involving the issue of six million new shares at $0.30 plus two million free attaching options with an exercise price of $0.20, is to be underwritten by Cunningham Securities.
Related News
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
